Bodal Chemicals Limited
Bodal Chemicals Limited engages in the manufacture and sale of dyestuffs, dyes intermediates, and other chemicals in India. The company's dye intermediates primarily include H-Acid, vinyl sulphone, K-Acid, gamma acid, DASA, FC acid, SPVS, OA sulpho VS, and beta naphthol; and dyestuffs, such as reactive dyes, acid dyes, direct dyes, and liquid dyes. It also provides chemicals comprising of sulphur… Read more
Bodal Chemicals Limited (BODALCHEM) - Total Liabilities
Latest total liabilities as of September 2025: ₹11.91 Billion INR
Based on the latest financial reports, Bodal Chemicals Limited (BODALCHEM) has total liabilities worth ₹11.91 Billion INR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Bodal Chemicals Limited - Total Liabilities Trend (2006–2025)
This chart illustrates how Bodal Chemicals Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Bodal Chemicals Limited Competitors by Total Liabilities
The table below lists competitors of Bodal Chemicals Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Dongkook Ind
KO:001620
|
Korea | ₩585.10 Billion |
|
Locksley Resources Ltd
AU:LKY
|
Australia | AU$340.64K |
|
Golden Insurance Brokers Co.,Ltd.
TWO:6028
|
Taiwan | NT$824.64 Million |
|
Isrotel -L
TA:ISRO
|
Israel | ILA2.62 Billion |
|
GavYam Lands Corp Ltd
TA:GVYM
|
Israel | ILA12.32 Billion |
|
Toplus Global Co Ltd
TWO:3522
|
Taiwan | NT$1.69 Billion |
|
ZK International Group Co Ltd
NASDAQ:ZKIN
|
USA | $38.25 Million |
|
Vilniaus Baldai AB
MU:UE3
|
Germany | €42.44 Million |
Liability Composition Analysis (2006–2025)
This chart breaks down Bodal Chemicals Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.14 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.04 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.06 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.51 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Bodal Chemicals Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Bodal Chemicals Limited (2006–2025)
The table below shows the annual total liabilities of Bodal Chemicals Limited from 2006 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | ₹12.48 Billion | +3.52% |
| 2024-03-31 | ₹12.06 Billion | +15.57% |
| 2023-03-31 | ₹10.43 Billion | -2.50% |
| 2022-03-31 | ₹10.70 Billion | +39.34% |
| 2021-03-31 | ₹7.68 Billion | +44.10% |
| 2020-03-31 | ₹5.33 Billion | +13.77% |
| 2019-03-31 | ₹4.68 Billion | +24.26% |
| 2018-03-31 | ₹3.77 Billion | +12.00% |
| 2017-03-31 | ₹3.37 Billion | +22.25% |
| 2016-03-31 | ₹2.75 Billion | -21.96% |
| 2015-03-31 | ₹3.53 Billion | -29.84% |
| 2014-03-31 | ₹5.03 Billion | +18.13% |
| 2013-03-31 | ₹4.26 Billion | -17.58% |
| 2012-03-31 | ₹5.16 Billion | +9.51% |
| 2011-03-31 | ₹4.72 Billion | +21.30% |
| 2010-03-31 | ₹3.89 Billion | +41.22% |
| 2009-03-31 | ₹2.75 Billion | +11.62% |
| 2008-03-31 | ₹2.47 Billion | +85.01% |
| 2007-03-31 | ₹1.33 Billion | +105.69% |
| 2006-03-31 | ₹648.10 Million | -- |